Detalhe da pesquisa
1.
Allodepleted T-cell immunotherapy after haploidentical haematopoietic stem cell transplantation without severe acute graft-versus-host disease (GVHD) in the absence of GVHD prophylaxis.
Br J Haematol
; 186(5): 754-766, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31135970
2.
CD56bright natural killer regulatory cells in filgrastim primed donor blood or marrow products regulate chronic graft-versus-host disease: the Canadian Blood and Marrow Transplant Group randomized 0601 study results.
Haematologica
; 102(11): 1936-1946, 2017 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935847
3.
Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study.
Biol Blood Marrow Transplant
; 22(8): 1410-1415, 2016 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-27154847
4.
Cell Therapy Transplant Canada (CTTC) Consensus-Based Guideline 2024 for Management and Treatment of Chronic Graft-Versus-Host Disease and Future Directions for Development.
Curr Oncol
; 31(3): 1426-1444, 2024 Mar 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-38534941
5.
Impact of Implementing a Bendamustine-Based Conditioning Regimen on Outcomes of Autologous Stem Cell Transplantation in Lymphoma while Novel Cellular Therapies Emerge.
Transplant Cell Ther
; 29(1): 34.e1-34.e7, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36243319
6.
Erratum to "Filgrastim-Stimulated Bone Marrow Compared with Filgrastim-Mobilized Peripheral Blood in Myeloablative Sibling Allografting for Patients with Hematologic Malignancies: A Randomized Canadian Blood and Marrow Transplant Group Study" [Biol Blood Marrow Transplant 2016;22:1410-1415].
Biol Blood Marrow Transplant
; 23(3): 534, 2017 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-27789277
7.
Donor Age and Non-Relapse Mortality: Study of Their Association after HLA-Matched Allogeneic Hematopoietic Cell Transplantation for Acute Myeloid Leukemia and Myelodysplastic Syndrome.
Curr Oncol
; 29(8): 5955-5962, 2022 08 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005208
8.
Real-World Outcomes of Autologous and Allogeneic Hematopoietic Stem Cell Transplantation for Relapsed/Refractory Hodgkin Lymphoma in the Era of Novel Therapies: A Canadian Perspective.
Transplant Cell Ther
; 28(3): 145-151, 2022 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-34954149
9.
Recognition of Hematopoietic Stem Cell Transplantation and Cellular Therapy Expertise to Promote Care Accessibility: A Formally Credentialed Area of Focused Competence in Canada.
Transplant Cell Ther
; 27(9): 702-706, 2021 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-34153503
10.
Autologous and allogeneic hematopoietic cell transplantation for diffuse large B-cell lymphoma-type Richter syndrome.
Blood Adv
; 5(18): 3528-3539, 2021 09 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-34496026
11.
ATIR101 administered after T-cell-depleted haploidentical HSCT reduces NRM and improves overall survival in acute leukemia.
Leukemia
; 34(7): 1907-1923, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32047237